Cancer genome analysis informatics

Methods in Molecular Biology

Volumn 628, Issue , 2010, Pages 75-102

  Barrett, Ian P ^a  

^a NONE

Author keywords

Array CGH; Bioinformatics; Cancer; Comparative genomic hybridisation; Database; Genome analysis; Mutation

Indexed keywords

DNA SEQUENCE; GENETICS; GENOME; GENOMICS; HUMAN; METHODOLOGY; NEOPLASM; REVIEW;

GENOME; GENOMICS; HUMANS; NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 84934443152     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-367-1_5     Document Type: Review

References (57)

1. CRUK published statistics-http://publications. cancerresearchuk.org/ WebRoot/cruk-storedb/CRUK-PDFs/CSINC08.pdf
2. World Health Organisation (WHO) cancer factsheet-http://www.who.int/ mediacen-tre/factsheets/fs297/en/index.html
3. Hanahan D, Weinberg RA. (2000) The hallmarks of cancer. Cell, 100, 57-70.
4. Steele RJ, Thompson AM, Hall PA, Lane DP. (1998) The p53 tumour suppressor gene. British Journal of Surgery, 85, 1460-1467.
5. Miki Y, Swensen J, ShattuckEidens D, Futreal PA, Harshman K, Tavtigian S et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
6. Druker BJ, Lydon NB. (2000) Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. Journal of Clinical Investigation, 105, 3-7.
7. Albanell J, Baselga J. (1999) The ErbB receptors as targets for breast cancer therapy. Journal of Mammary Gland Biology & Neoplasia, 4, 337-351.
8. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002) Mutations of the BRAF gene in human cancer. Nature, 417, 949-954.
9. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. (2006) The consensus coding sequences of human breast and col-orectal cancers. Science, 314, 268-274.
10. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature, 446, 153-158.
11. Tomlins SA, Rhodes DR, Perner S, Dhana-sekaran SM, Mehra R, Sun XW et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science, 310, 644-648.
12. Khalique L, Ayhan A, Weale ME, Jacobs IJ, Ramus SJ, Gayther SA. (2007) Genetic intra-tumour heterogeneity in epithelial ovarian cancer and its implications for molecular diagnosis of tumours. Journal of Pathology, 211, 286-295.
13. Tang X, Shigematsu H, Bekele BN, Roth JA, Minna JD, Hong WK et al. (2005) EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Research, 65, 7568-7572.
14. Campbell PJ, et al. (2008) Identifcation of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nature Genetics, 40, 722-729.
15. http://www.sanger.ac.uk/genetics/CGP/
16. http://cancergenome.nih.gov/index.asp
17. http://www.icgc.org/
18. Bardelli A, Parsons DW, Silliman N, Ptak J, Szabo S, Saha S et al. (2003) Mutational analysis of the tyrosine kinome in colorectal cancers. Science, 300, 949.
19. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature, 450, 893-898.
20. Mitelman Database of Chromosome Aberrations in Cancer (2008). Mitelman F, Johansson B, and Mertens F (Eds.), http://cgap.nci.nih.gov/Chromosomes/Mitelman
21. Knutsen T, Gobu V, Knaus R, PadillaNash H, Augustus M, Strausberg RL et al. (2005) The interactive online SKY/M-FISH & CGH database and the Entrez cancer chromosomes search database: linkage of chromosomal aberrations with the genome sequence. Genes, Chromosomes & Cancer, 44, 52-64.
22. Huret JL, Senon S, Bernheim A, Dessen P. (2004) An Atlas on genes and chromosomes in oncology and haematology. Cellular & Molecular Biology, 50, 805-807.
23. Baudis M, Cleary ML. (2001) Progenetix. net: an online repository for molecular cyto-genetic aberration data. Bioinformatics, 17, 1228-1229.
24. Kim DS, Huh JW, Kim HS. (2007) HYBRIDdb: a database of hybrid genes in the human genome. BMC Genomics, 8, 128.
25. Kim N, Kim P, Nam S, Shin S, Lee S. (2006) ChimerDB-a knowledgebase for fusion sequences. Nucleic Acids Research, 34, 21-4.
26. Baross A, Delaney AD, Li HI, Nayar T, Flibotte S, Qian H et al. (2007) Assessment of algorithms for high throughput detection of genomic copy number variation in oligonu-cleotide microarray data. BMC Bioinformatics, 8, 368.
27. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S et al. (2004) Bioconductor: open software development for computational biology and bioinformat-ics. Genome Biology, 5, R80.
28. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP. (2006) GenePattern 2.0. Nature Genetics, 38, 500-501.
29. Hupe P, Stransky N, Thiery JP, Radvanyi F, Barillot E. (2004) Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics, 20, 3413-3422.
30. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D et al. (2007) Assessing the signifcance of chromosomal aberrations in cancer: methodology and application to glioma. Proceedings of the National Academy of Sciences of the United States of America, 104, 20007-20012.
31. Flicek P, Aken BL, Beal K, Ballester B, Caccamo M, Chen Y et al. (2008) Ensembl 2008. Nucleic Acids Research, 36, 707-14.
32. Karolchik D, Kuhn RM, Baertsch R, Barber GP, Clawson H, Diekhans M et al. (2008) The UCSC Genome Browser Database: 2008 update. Nucleic Acids Research, 36, 773-9.
33. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, Chetvernin V et al. (2008) Database resources of the National Center for Biotechnology Information. Nucleic Acids Research, 36, 13-21.
34. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplifed in malignant melanoma. Nature, 436, 117-122.
35. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C et al. (2007) NCBI GEO: mining tens of millions of expression profles-database and tools update. Nucleic Acids Research, 35, 760-5.
36. Parkinson H, Kapushesky M, Shojatalab M, Abeygunawardena N, Coulson R, Farne A et al. (2007) ArrayExpress-a public database of microarray experiments and gene expression profles. Nucleic Acids Research, 35, 745-50.
37. Demeter J, Beauheim C, Gollub J, HernandezBoussard T, Jin H, Maier D et al. (2007) The Stanford Microarray Database: implementation of new analysis tools and open source release of software. Nucleic Acids Research, 35, 766-70.
38. Chari R, Lockwood WW, Coe BP, Chu A, Macey D, Thomson A et al. (2006) SIGMA: a system for integrative genomic microarray analysis of cancer genomes. BMC Genomics, 7, 324.
39. Hupe P, La Rosa P, Liva S, Lair S, Servant N, Barillot E. (2007) ACTuDB, a new database for the integrated analysis of array-CGH and clinical data for tumors. Oncogene, 26, 6641-6652.
40. Scheinin I, Myllykangas S, Borze I, Bohling T, Knuutila S, Saharinen J. (2008) CanGEM: mining gene copy number changes in cancer. Nucleic Acids Research, 36, 830-835.
41. Reyal F, Stransky N, BernardPierrot I, VincentSalomon A, de Rycke Y, Elvin P et al. (2005) Visualizing chromosomes as transcrip-tome correlation maps: evidence of chromosomal domains containing co-expressed genes-a study of 130 invasive ductal breast carcinomas. Cancer Research, 65, 1376-1383.
42. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D et al. (2008) Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nature Genetics, 40, 281-283.
43. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG et al. (2007) Genome-wide association study identifes novel breast cancer susceptibility loci. Nature, 447, 1087-1093.
44. Forbes S, Clements J, Dawson E, Bamford S, Webb T, Dogan A et al. (2005) Cosmic 2005. British Journal of Cancer, 94, 318-322.
45. Hamroun D, Kato S, Ishioka C, Claustres M, Beroud C, Soussi T. (2006) The UMD TP53 database and website: update and revisions. Human Mutation, 27, 14-20.
46. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P et al. (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Human Mutation, 28, 622-629.
47. Pollock PM, Gartside MG, Dejeza LC, Powell MA, Mallon MA, Davies H et al. (2007) Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene, 26, 7158-7162.
48. Ortutay C, Valiaho J, Stenberg K, Vihinen M. (2005) KinMutBase: a registry of disease-causing mutations in protein kinase domains. Human Mutation, 25, 435-442.
49. Zhang J, Finney RP, Rowe W, Edmonson M, Yang SH, Dracheva T et al. (2007) Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB). Genome Research, 17, 1111-1117.
50. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R et al. (2004) A census of human cancer genes. Nature Reviews Cancer, 4, 177-183.
51. Caporaso JG, Baumgartner WA, Jr., Randolph DA, Cohen KB, Hunter L. (2007) Mutation-Finder: a high-performance system for extracting point mutation mentions from text. Bio-informatics, 23, 1862-1865.
52. Emuss V, Garnett M, Mason C, Marais R. (2005) Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF. Cancer Research, 65, 9719-9726.
53. Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F et al. (2007) Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell, 12, 115-130.
54. Perry GH, BenDor A, Tsalenko A, Sampas N, RodriguezRevenga L, Tran CW et al. (2008) The fne-scale and complex architecture of human copy-number variation. American Journal of Human Genetics, 82, 685-695.
55. ENCODE Project Consortium, Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR et al. (2007) Identifcation and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature, 447, 799-816.
56. Soussi T, Ishioka C, Claustres M, Beroud C. (2006) Locus-specifc mutation databases: pitfalls and good practice based on the p53 experience. Naturev Reviews Cancer, 6, 83-90.
57. Torkamani A, Schork NJ. (2008) Prediction of cancer driver mutations in protein kinases. Cancer Research, 68, 1675-1682.